Precigen (PGEN) Share-based Compensation (2012 - 2026)

Precigen (PGEN) reported Share-based Compensation of $3.0 million for Q1 2026, up 12.29% year-over-year from $2.7 million in Q1 2025, and up 38.97% quarter-over-quarter from $2.2 million in Q4 2025.

Precigen (PGEN) Share-based Compensation (2012 - 2026) Analysis & Trends

Precigen (PGEN) has 15 years of Share-based Compensation data on file, last reported at $3.0 million in Q1 2026.

  • Share-based Compensation for Q1 2026 came in at $3.0 million, up 12.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.2 million (up 17.02% YoY), and the FY2025 annual result was $10.9 million, up 14.73% from the prior year.
  • Share-based Compensation advanced to $3.0 million in Q1 2026 per PGEN's latest filing, from $2.2 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $4.4 million in Q3 2025 and troughed at $1.6 million in Q2 2025.
  • A 5-year average of $2.6 million and a median of $2.3 million in 2023 frame the typical range for Share-based Compensation.
  • The sharpest annual moves came in 2022 and 2025: Share-based Compensation plunged 35.09% in 2022, then soared 112.91% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $2.2 million in 2022, then climbed by 2.35% to $2.3 million in 2023, then advanced by 26.66% to $2.9 million in 2024, then retreated by 24.5% to $2.2 million in 2025, then soared by 38.97% to $3.0 million in 2026.
  • Business Quant data shows PGEN's Share-based Compensation at $3.0 million in Q1 2026, $2.2 million in Q4 2025, and $4.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 305,000.00
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 166.40 Mn
9 Abivax 94.37 Bn 94.37 Bn - 26.47 Mn
10 Precigen 1.27 Bn 1.27 Bn 20.69 Mn 3.01 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.01 Mn
Mar 31, 2026 3.01 Mn
Dec 31, 2025 2.16 Mn
Dec 31, 2025 2.16 Mn
Sep 30, 2025 4.39 Mn
Sep 30, 2025 4.39 Mn
Jun 30, 2025 1.64 Mn
Jun 30, 2025 1.64 Mn
Mar 31, 2025 2.68 Mn
Mar 31, 2025 2.68 Mn
Dec 31, 2024 2.87 Mn
Dec 31, 2024 2.87 Mn
Sep 30, 2024 2.06 Mn
Sep 30, 2024 2.06 Mn
Jun 30, 2024 1.96 Mn
Jun 30, 2024 1.96 Mn
Mar 31, 2024 2.58 Mn
Mar 31, 2024 2.58 Mn
Dec 31, 2023 2.26 Mn
Dec 31, 2023 2.26 Mn